Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
600 participants
INTERVENTIONAL
2004-05-31
2005-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adult Asthmatics and Acid Reflux
NCT00628953
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00626535
Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
NCT00206024
Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
NCT02708355
Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
NCT00317044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Esomeprazole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of pain or discomfort in the chest for at least the last two weeks prior to enrollment.
Exclusion Criteria
* Patients whose pain or discomfort in the chest warrants urgent cardiac investigation.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca Nexium Medical Sciences Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Penticton, British Columbia, Canada
Research Site
Winkler, Manitoba, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Burlington, Ontario, Canada
Research Site
Etobicoke, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
North York, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Windsor, Ontario, Canada
Research Site
Charlottetown, Prince Edward Island, Canada
Research Site
Saint-Léonard, Quebec, Canada
Research Site
Saskatoon, Saskatchewan, Canada
Research Site
Charlottenlund, , Denmark
Research Site
Elsinore, , Denmark
Research Site
Esbjerg, , Denmark
Research Site
Frederiksberg, , Denmark
Research Site
Frederikssund, , Denmark
Research Site
Herning, , Denmark
Research Site
Hillerød, , Denmark
Research Site
Kolding, , Denmark
Research Site
København K, , Denmark
Research Site
København NV, , Denmark
Research Site
Odense, , Denmark
Research Site
Odense C, , Denmark
Research Site
Randers, , Denmark
Research Site
Vejle, , Denmark
Research Site
Stuttgart, Baden-Wurttemberg, Germany
Research Site
Augsburg, Bavaria, Germany
Research Site
Hanover, Lower Saxony, Germany
Research Site
Saarbrücken, Saarland, Germany
Research Site
Dresden, Saxony, Germany
Research Site
Halle, Saxony-Anhalt, Germany
Research Site
Bad Segeberg, Schleswig-Holstein, Germany
Research Site
Berlin, State of Berlin, Germany
Research Site
Augsburg, , Germany
Research Site
Bad Segeberg, , Germany
Research Site
Berlin, , Germany
Research Site
Chemnitz, , Germany
Research Site
Dillingen, , Germany
Research Site
Dresden, , Germany
Research Site
Görlitz, , Germany
Research Site
Hermaringen, , Germany
Research Site
Leipzig, , Germany
Research Site
Löbau, , Germany
Research Site
Magdeburg, , Germany
Research Site
Münster, , Germany
Research Site
Weener, , Germany
Research Site
Wolmirstedt, , Germany
Research Site
Lichtenvoorde, Gelderland, Netherlands
Research Site
Deurne, North Brabant, Netherlands
Research Site
Oldebroek, Overijssel, Netherlands
Research Site
Hoogvliet, South Holland, Netherlands
Research Site
Rijswijk, South Holland, Netherlands
Research Site
Roelofarendsveen, South Holland, Netherlands
Research Site
Rotterdam, South Holland, Netherlands
Research Site
's-Hertogenbosch, , Netherlands
Research Site
Beek en Donk, , Netherlands
Research Site
Hoogwoud, , Netherlands
Research Site
Huizen, , Netherlands
Research Site
Nijverdal, , Netherlands
Research Site
Spijkenisse, , Netherlands
Research Site
Tilburg, , Netherlands
Research Site
Bergen, , Norway
Research Site
Gjøvik, , Norway
Research Site
Hønefoss, , Norway
Research Site
Nestun, , Norway
Research Site
Oslo, , Norway
Research Site
Skedsmokorset, , Norway
Research Site
Åkersberga, , Sweden
Research Site
Gothenburg, , Sweden
Research Site
Krokom, , Sweden
Research Site
Norrtälje, , Sweden
Research Site
Östersund, , Sweden
Research Site
Stockholm, , Sweden
Research Site
Trollhättan, , Sweden
Research Site
Umeå, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wade D, Cooper J, Derry F, Taylor J. Uro-Vaxom(R) versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study. Trials. 2019 Apr 16;20(1):223. doi: 10.1186/s13063-019-3275-x.
Flook NW, Moayyedi P, Dent J, Talley NJ, Persson T, Karlson BW, Ruth M. Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2013 Jan;108(1):56-64. doi: 10.1038/ajg.2012.369. Epub 2012 Nov 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D9914C00001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.